Cargando…

Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer

Lysine-specific demethylase 6A (KDM6A) and members of the Switch/Sucrose Non-Fermentable (SWI/SNF) family are known to counteract the activity of Enhancer of Zeste Homolog 2 (EZH2), which is often overexpressed and is associated with poor prognosis in muscle-invasive bladder cancer. Here we provide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramakrishnan, Swathi, Granger, Victoria, Rak, Monika, Hu, Qiang, Attwood, Kristopher, Aquila, Lanni, Krishnan, Nithya, Osiecki, Rafal, Azabdaftari, Gissou, Guru, Khurshid, Chatta, Gurkamal, Gueron, Geraldine, McNally, Lacey, Ohm, Joyce, Wang, Jianmin, Woloszynska, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748105/ https://www.ncbi.nlm.nih.gov/pubmed/30692641 http://dx.doi.org/10.1038/s41418-019-0278-9

Ejemplares similares

Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer
por: Ramakrishnan, Swathi, et al.
Publicado: (2017)

STAG2 Expression is Associated with Adverse Survival Outcomes and Regulates Cell Phenotype in Muscle-invasive Bladder Cancer
por: Athans, Sarah R., et al.
Publicado: (2022)

Serum Androgen Metabolites Correlate with Clinical Variables in African and European American Men with Localized, Therapy Naïve Prostate Cancer
por: Ramakrishnan, Swathi, et al.
Publicado: (2023)

Clinicopathologic characterization of intradiverticular carcinoma of urinary bladder - a study of 22 cases from a single cancer center
por: Zhong, Hua, et al.
Publicado: (2014)

NFκB-Activated COX2/PGE(2)/EP4 Axis Controls the Magnitude and Selectivity of BCG-Induced Inflammation in Human Bladder Cancer Tissues
por: Ibrahim, Omar M., et al.
Publicado: (2021)

Establishment and Characterization of a Highly Tumorigenic African American Prostate Cancer Cell Line, E006AA-hT
por: Koochekpour, Shahriar, et al.
Publicado: (2014)

Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer
por: Kirk, Jason S., et al.
Publicado: (2014)

YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage
por: Ciamporcero, Eric, et al.
Publicado: (2015)

Vitamin D(3) enhances the response to cisplatin in bladder cancer through VDR and TAp73 signaling crosstalk
por: Bunch, Brittany L., et al.
Publicado: (2019)

Role of tumor microenvironment in the efficacy of BCG therapy
por: Ibrahim, Omar M, et al.
Publicado: (2020)

Generation of a syngeneic orthotopic transplant model of prostate cancer metastasis
por: Ellis, Leigh, et al.
Publicado: (2014)

Inhibition of dihydrotestosterone synthesis in prostate cancer by combined frontdoor and backdoor pathway blockade
por: Fiandalo, Michael V., et al.
Publicado: (2018)

T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors
por: Yamauchi, Takayoshi, et al.
Publicado: (2021)

Enhanced efficacy of sitravatinib in metastatic models of antiangiogenic therapy resistance
por: Dolan, Melissa, et al.
Publicado: (2019)

Prostate cancer as a dedifferentiated organ: androgen receptor, cancer stem cells, and cancer stemness
por: Liu, Xiaozhuo, et al.
Publicado: (2022)

Association between Functional Brain Network Metrics and Surgeon Performance and Distraction in the Operating Room
por: Shafiei, Somayeh B., et al.
Publicado: (2021)

Aldehyde dehydrogenase and ATP binding cassette transporter G2 (ABCG2) functional assays isolate different populations of prostate stem cells where ABCG2 function selects for cells with increased stem cell activity
por: Gangavarapu, Kalyan J, et al.
Publicado: (2013)

Combinatorial antitumor effect of HDACs and the PI3K-Akt-mTOR pathway inhibition in a Pten deficient model of prostate cancer
por: Ellis, Leigh, et al.
Publicado: (2013)

Loss of MAGEC3 Expression Is Associated with Prognosis in Advanced Ovarian Cancers
por: Ellegate, James, et al.
Publicado: (2022)

Human Prostate Side Population Cells Demonstrate Stem Cell Properties in Recombination with Urogenital Sinus Mesenchyme
por: Foster, Barbara A., et al.
Publicado: (2013)

Metastatic phenotype in CWR22 prostate cancer xenograft following castration
por: Seedhouse, Steven J., et al.
Publicado: (2015)

Cost-Effectiveness Analysis of Adjuvant Stage III Colon Cancer Treatment at Veterans Affairs Medical Centers
por: Soni, Amy, et al.
Publicado: (2015)

Tumor-associated macrophage expression of interferon regulatory Factor-8 (IRF8) is a predictor of progression and patient survival in renal cell carcinoma
por: Muhitch, Jason B., et al.
Publicado: (2019)

The role of EZH1 and EZH2 in development and cancer
por: Lee, Soo Hyun, et al.
Publicado: (2022)

A randomized phase II study of pazopanib in hormone sensitive prostate cancer: a University of Chicago Phase II Consortium/ Department of Defense Prostate Cancer Clinical Trials Consortium study
por: Ward, James E., et al.
Publicado: (2011)

Case Report: Immune Checkpoint Inhibitor-Induced Exuberant Tumor Inflammation With Accelerated Clinical Deterioration in Metastatic Renal Cell Carcinoma
por: Gopalakrishnan, Dharmesh, et al.
Publicado: (2021)

EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer
por: Chinaranagari, Swathi, et al.
Publicado: (2014)

Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy
por: Affronti, Hayley C., et al.
Publicado: (2020)

Phase 1b trial of proteasome inhibitor carfilzomib with irinotecan in lung cancer and other irinotecan-sensitive malignancies that have progressed on prior therapy (Onyx IST reference number: CAR-IST-553)
por: Arnold, Susanne M., et al.
Publicado: (2017)

Editorial: Molecular imaging for tracking drug delivery
por: Han, Zheng, et al.
Publicado: (2023)

Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors
por: Shinohara, Haruka, et al.
Publicado: (2022)

Diabetes, Obesity, and Inflammation: Impact on Clinical and Radiographic Features of Breast Cancer
por: Miller, Braden, et al.
Publicado: (2021)

Imaging Inflammation and Infection in the Gastrointestinal Tract
por: Frickenstein, Alex N., et al.
Publicado: (2019)

Association among plasma 1,25(OH)(2)D, ratio of 1,25(OH)(2)D to 25(OH)D, and prostate cancer aggressiveness
por: Ramakrishnan, Swathi, et al.
Publicado: (2019)

Targeted Disruption of the EZH2/EED Complex Inhibits EZH2-dependent Cancer
por: Kim, Woojin, et al.
Publicado: (2013)

The spindle assembly function of Caenorhabditis elegans katanin does not require microtubule-severing activity
por: McNally, Karen Perry, et al.
Publicado: (2011)

Durability of antibody response to vaccination and surrogate neutralization of emerging variants based on SARS-CoV-2 exposure history
por: McDade, Thomas W., et al.
Publicado: (2021)

EZH2 in Myeloid Malignancies
por: Rinke, Jenny, et al.
Publicado: (2020)

Tazemetostat: EZH2 Inhibitor
por: Straining, Rachael, et al.
Publicado: (2022)

Regulation of Histone Ubiquitination in Response to DNA Double Strand Breaks
por: Aquila, Lanni, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u5879eslajvfu1le9qjpffa8va